found that in 81 CRC patients, a high CD163+/CD68+ ratio at the front of tumor invasion (rather than at the tumor stroma) was closely related to enhance lymphatic vascular invasion, tumor invasion, TNM stage, RFS and OS in CRC patients (65). This evidence concerns the gene CD68 and neoplasm.